Osang Healthcare

At a glance

Osang Healthcare filed 29 disclosures in the last 12 months, including 4 insider, 2 buyback, 1 contract and 1 5% holder. The most recent key filing was on May 13.

Revenue for 2025 was ₩129B, up 59.8% on 2024. Operating margin was 1.9% against -30.8% a year earlier. Debt was 20% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩42B and operating loss of ₩12.5B.

The 2025 annual report lists 336 employees with an average tenure of 6.1 years and average pay of ₩57M, #1121 of 1,829 listed companies by average pay. Its 8 directors and auditors were paid ₩151M each on average. It paid ₩200 per common share in cash dividends, against ₩500 a year earlier (-60%). ㈜오상 and related parties held 56.19% at year end.

From the 2025 annual report

Staff: 336 (152 men, 184 women), of whom 14 on fixed-term contracts. Total pay for the year: ₩19.2B. Directors and auditors: 8, paid ₩1.2B in total.

Dividends (common shares)

Largest shareholder

㈜오상 holds 34.26%; with 6 related parties the group holds 56.19% of common shares at year end (from 55.27% at the start of the year).

Individuals paid ₩500M or more

Auditor: 삼화회계법인 · opinion: Unqualified.

Rankings: Revenue growth #41 of 1,376

Source: 2025 annual business report (DART). How figures are combined

Financial summary